| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 19 |
| 1 | DEXAMETHASONE | 17 |
| 2 | DEXAMETHASONE 1.5 MG | 17 |
| 3 | LENALIDOMIDE | 16 |
| 4 | MELPHALAN | 16 |
| 5 | MELPHALAN HYDROCHLORIDE | 16 |
| 6 | CISPLATIN | 15 |
| 7 | CYCLOPHOSPHAMIDE | 15 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 15 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MICAFUNGIN SODIUM | 11 | 0.0017 |
| 1 | MARAVIROC | 3 | 0.0013 |
| 2 | DISOPYRAMIDE PHOSPHATE | 1 | 0.0012 |
| 3 | AMILORIDE HYDROCHLORIDE | 1 | 0.0012 |
| 4 | DARUNAVIR ETHANOLATE AND COBICISTAT | 2 | 0.0011 |
| 5 | PSYLLIUM HUSK | 1 | 0.0007 |
| 6 | BENDAMUSTINE HYDROCHLORIDE | 6 | 0.0007 |
| 7 | FLUNISOLIDE | 1 | 0.0007 |
| 8 | CEFACLOR | 1 | 0.0006 |
| 9 | GOLIMUMAB | 8 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 37 |
| 1 | Corticosteroid [EPC] | 36 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 31 |
| 3 | Platinum-based Drug [EPC] | 18 |
| 4 | Thalidomide Analog [EPC] | 18 |
| 5 | Alkylating Drug [EPC] | 15 |
| 6 | Azole Antifungal [EPC] | 15 |
| 7 | Proton Pump Inhibitor [EPC] | 15 |
| 8 | Topoisomerase Inhibitor [EPC] | 15 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 1 | Echinocandin Antifungal [EPC] | 11 | 0.0013 |
| 2 | CCR5 Co-receptor Antagonist [EPC] | 3 | 0.0013 |
| 3 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 5 | beta Lactamase Inhibitor [EPC] | 2 | 0.0004 |
| 6 | Human Immunoglobulin G [EPC] | 9 | 0.0004 |
| 7 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 9 | Interleukin-17A Antagonist [EPC] | 10 | 0.0003 |